Dow Down 0.06% Nasdaq Up 0.61%

CytRx Corporation (CYTR)

-NasdaqCM
2.57 Up 0.02(0.59%) 1:09PM EST - Nasdaq Real Time Price
Prev Close:2.55
Open:2.55
Bid:2.56 x 2300
Ask:2.57 x 41400
1y Target Est:11.00
Beta:1.16
Next Earnings Date:N/A
Day's Range:2.54 - 2.59
52wk Range:2.19 - 8.35
Volume:308,595
Avg Vol (3m):820,591
Market Cap:142.96M
P/E (ttm):N/A
EPS (ttm):-0.87
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTRUp 0.59%142.96M
LLYDown 0.48%71.71B
NVSDown 0.33%228.97B
SNYDown 0.21%123.47B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,421.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.65
Quarterly EPS Est (Dec-14) :-0.26
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback